Cardiovascular and diabetic diseases are no longer confined to the elderly or high-risk groups—they have become widespread lifestyle conditions affecting people across age groups in India. Sedentary habits, poor dietary choices, stress, and genetic predispositions are driving alarming rates of hypertension, diabetes, and heart disease. According to the Indian Council of Medical Research (ICMR), nearly 77 million people in India live with diabetes and one in every four deaths is linked to cardiovascular diseases.These statistics highlight an urgent need for advanced, safe, and accessible treatments that go beyond conventional therapy. This is where Innovative Pharmaceuticals Pvt. Ltd. is making a difference, with its carefully developed cardio-diabetic range that focuses on precision, safety, and patient convenience.

The Challenge of Cardio-Diabetic Care in India

Managing cardiovascular and diabetic conditions is complex because patients often deal with multiple health issues simultaneously. For instance:

• A diabetic patient may also suffer from hypertension.
• Cardiovascular patients often need cholesterol-lowering drugs, blood thinners, and blood pressure medications together.
• Long-term medication leads to polypharmacy, where patients juggle multiple tablets every day, risking non-compliance and side effects.

The real challenge lies in balancing efficacy, safety, and patient compliance. Traditional therapies often fall short because they either burden patients with too many pills or cause side effects that make treatment unsustainable.

Innovative’s Cardio-Diabetic Range

At Innovative Pharmaceuticals Pvt. Ltd., we are dedicated to improving the quality of life through scientifically formulated, result-oriented medicines in the cardio-diabetic segment. With a wide portfolio covering over 250+ products, we aim to provide doctors, retailers, and distributors with a complete range under one trusted brand.

With a commitment to innovation, quality, and accessibility, we ensure our partners have everything they need to meet patient demands efficiently and confidently.

Innovative Pharmaceuticals Pvt. Ltd. covers a wide spectrum of therapeutic categories, including:

• Anti-diabetic medications – Designed for optimal glycemic control with minimal side effects.
• Antihypertensive therapies – Targeting high blood pressure safely and effectively.
• Lipid-lowering drugs – Helping reduce cholesterol and triglycerides.
• Antiplatelet and anticoagulant medicines – Preventing clot formation in high-risk patients.
• Cardio-protective supplements – Supporting long-term heart health.

 Explore Innovative’s Cardio-Diabetic Care Range

These medicines are developed with a focus on bioavailability, stability, and patient safety, ensuring global-standard quality at affordable prices.

Innovative Pharmaceuticals Pvt. Ltd. – Comprehensive Cardio-Diabetic Care Under One Roof

Our products are developed using evidence-based formulations that meet stringent quality standards—ensuring safety, efficacy, and affordability for every patient.

Cardiac Range

1. Amlopride AT Tablets

Composition: Amlodipine 5 mg + Atenolol 50 mg

Purpose: Helps manage hypertension and angina by reducing heart rate and relaxing blood vessels, improving blood flow.

2. Atrsosure 10 Tablet

Composition: Atorvastatin 10 mg

Purpose: Lowers LDL cholesterol and triglycerides while increasing HDL levels; prevents cardiovascular complications.

3. Clopizest-A 75 Capsule

Composition: Clopidogrel 75 mg + Aspirin 75 mg

Purpose: Antiplatelet combination used to prevent blood clots, stroke, and heart attack in patients with coronary artery disease.

4. Telmizest H 40 Tablet

Composition: Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg

Purpose: Controls high blood pressure effectively, reducing strain on the heart and risk of future cardiac events.

5. Metozest XL 50 Tablet

Composition: Metoprolol Succinate 50 mg (Extended-Release)

Purpose: Beta-blocker used in managing hypertension, angina, and heart failure by improving cardiac efficiency.

Diabetic Range

6. Glycirest G1 Tablet

Composition: Glimepiride 1 mg + Metformin 500 mg

Purpose: Combination oral antidiabetic agent that improves insulin sensitivity and controls blood sugar levels effectively.

7. Dapacan-M 10 | 500 Tablet

Composition: Dapagliflozin 10 mg + Metformin 500 mg

Purpose: SGLT2 inhibitor combination that controls glucose reabsorption in kidneys, supporting better glycemic control and weight management.

8. Voglizest-0.3 Tablet

Composition: Voglibose 0.3 mg

Purpose: Alpha-glucosidase inhibitor that slows carbohydrate absorption, minimizing post-meal sugar spikes.

9. Tenezide M 500 Tablet

Composition: Teneligliptin 20 mg + Metformin 500 mg

Purpose: Dual mechanism DPP-4 inhibitor that enhances insulin secretion and lowers blood glucose levels effectively.

10. Ticapride 90 Tablet

Composition: Ticagrelor 90 mg

Purpose: Ticagrelor is an antiplatelet medication used to prevent blood clots, which reduces the risk of heart attacks and strokes in high-risk patients. 

Innovation Meets Affordability

While advanced therapies often remain out of reach for average Indian patients due to high costs, Innovative bridges this gap by:

• Maintaining affordable pricing without compromising quality.
• Supporting government initiatives like PMBJK to make medicines widely accessible.
• Offering therapies tailored for Indian demographics, ensuring relevance and affordability.
  Conclusion

Cardio-diabetic care requires more than just medicines—it demands trust, innovation, and patient focus. With its targeted and safer combinations, Innovative Pharmaceuticals Pvt. Ltd. has emerged as a leader in cardio care, helping patients live longer, healthier, and more fulfilling lives.

Whether it’s managing hypertension, diabetes, or cholesterol together, Innovative Pharmaceuticals Pvt. Ltd. ensures that every formulation delivers on the promise of safety, efficacy, and affordability.